Johnson & Johnson's Bullish Outlook: Surprising Strength You Shouldn't Overlook
Johnson & Johnson is a Dividend King focused on the creation and manufacturing of medical devices, vaccines, and medicines. Sales of Darzalex, an anti-CD38 monoclonal antibody, were $2.5 billion in...
Johnson & Johnson: A Defensive Dividend King Set To Outperform The S&P 500
Johnson & Johnson is a safe and stable business with an AAA rating and a 60+ year history of dividend increases. JNJ has a strong balance sheet, generating significant free cash flow and having the...
Johnson & Johnson - One Of The World's Safest Stocks Could Return +10% Per Year
The Fed's potential rate cuts are causing concern in the market, as it could lead to higher inflation and negatively impact stocks. Johnson & Johnson (JNJ) is a safe investment option with a histor...
Johnson & Johnson (JNJ) Rises As Market Takes a Dip: Key Facts
In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $160.97, denoting a +0.63% change from the preceding trading day.
2024's Blue-Chip Winners: Top 3 Stocks for Rock-Solid Returns
Blue-chip stocks act as a portfolio anchor that prevents steep losses. And, they often pay substantial dividends that can keep returns ticking over amid market volatility.
Judge certifies Johnson & Johnson shareholder class action over talc disclosures
A federal judge said Johnson & Johnson shareholders may pursue as a class action their lawsuit accusing the company of concealing how its talc products were contaminated by asbestos.
Judge certifies Johnson & Johnson shareholder class action over talc disclosures
A federal judge said Johnson & Johnson shareholders may pursue as a class action their lawsuit accusing the company of fraudulently of concealing how its talc products were contaminated by cancer-c...
Johnson & Johnson (JNJ) Laps the Stock Market: Here's Why
In the most recent trading session, Johnson & Johnson (JNJ) closed at $156.58, indicating a +0.15% shift from the previous trading day.
Safe Havens: 3 Fixed-Income Securities for a Balanced Portfolio in 2024
Although next year looks to be a good time to invest in risk assets like Bitcoin ( BTC-USD ), investors with a lower risk tolerance look toward safe havens to grow their income. Some of these haven...
Johnson & Johnson: Ottava Surgical Robot Is A Growth Tailwind
Johnson & Johnson is entering the surgical robotics market with the Ottava surgical system, potentially gaining a strong market position. Ottava's design offers competitive advantages over the domi...
Build Your Future Portfolio: 3 Generous Dividend Stocks
You heard it here: 2024 could be an excellent year for stocks. The economy is improving, and specifically the third-quarter results were better than expected.
Johnson & Johnson (JNJ) Increases Yet Falls Behind Market: What Investors Need to Know
In the latest trading session, Johnson & Johnson (JNJ) closed at $155.44, marking a +0.18% move from the previous day.
Stock Movers: J&J, Vertex Pharma and Tesla
The “Halftime Report” Investment Committee debate the market movers they own.
J&J (JNJ) Announces 2024 and Long-Term Financial Outlook
J&J (JNJ) expects operational sales growth in the range of 5-6% in 2024, driven by both its Innovative Medicine and MedTech divisions.
Johnson & Johnson (JNJ) Sees a More Significant Dip Than Broader Market: Some Facts to Know
In the latest trading session, Johnson & Johnson (JNJ) closed at $158.55, marking a -0.21% move from the previous day.
Related Companies